NDRA
NDRA
NASDAQ · Health Care

Endra Life Sciences Inc

$5.29
+0.29 (+5.80%)
As of Jun 30, 4:56 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +511.3% upside
Low Target $22.21
Average Target $32.34
High Target $49.71
Current Price $5.29
Current
$5.29
Target
$32.34
$22.21 $32.34 avg $49.71
Scenario Analysis
Bear Case
$22.21
319.8%
Low target
Base Case
$32.34
+511.3%
Avg target
Bull Case
$49.71
+839.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$11.96
-55.8% from high
52-Week Low
$2.96
+78.7% from low
Target vs 52W High
$32.34
+170.4% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 34 76% $293.85 -29.4%
ABT
Abbott Laboratories
Buy 34 71% $123.47 +35.6%
ISRG
Intuitive Surgical Inc
Buy 40 70% $219.77 -45.1%
CVS
Cvs Health Corp
Strong Buy 33 82% $162.09 +55.9%
SYK
Stryker Corp
Strong Buy 35 77% $338.36 +8.4%
MDT
Medtronic Plc
Buy 37 57% $192.46 +144.2%
MCK
Mckesson Corp
Strong Buy 23 87% $307.39 -59.2%
HCA
Hca Healthcare Inc
Buy 30 63% $118.82 -69.4%